Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  European Journal of Pharmacology

• Publication date

  1978-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(78)90340-0PMID 699981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain

  2004cited by this paper
• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Prolactin-lowering effect of low doses of lisuride in man.

  1978cited by this paper
• Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.

  1977cited by this paper
• Action of classic and unusual neuroleptics on various behavioral apomorphine-induced effects.

  1977cited by this paper
• Induction of mounting behaviour in female and male rats by lisuride.

  1977cited by this paper
• Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.

  1977cited by this paper
• Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.

  1977cited by this paper
• Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.

  1977cited by this paper
• Dopaminergic autoreceptors: background and implications.

  1977cited by this paper
• Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in parkinsonism

  1976cited by this paper
• Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.

  1976cited by this paper
• Effects of ergot alkaloids on the hypothalamic-pituitary axis.

  1976cited by this paper
• STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPA

  1976cited by this paper
• Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.

  1976cited by this paper
• Effects of bromocriptine on central dopaminergic receptors.

  1976cited by this paper
• Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

  1976cited by this paper
• Antagonism by sulpiride of three apomorphine-induced effects in rodents.

  1976cited by this paper
• Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain.

  1975cited by this paper
• Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.

  1975cited by this paper
• Influence of apomorphine hydrochloride, dibutyrylapomorphine and Lysenyl on plasma prolactin concentrations in the rat

  1975cited by this paper
• Bromocriptine in Parkinsonism

  1974cited by this paper
• Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons

  1973cited by this paper
• Biochemical and pharmacological aspects of Parkinsonism.

  1972cited by this paper
• Advances in biochemical psychopharmacology: Volume 1, edited by E. Costa and P. Greengard, Raven press (1969)

  1970cited by this paper
• The occurrence, distribution and physiological role of catecholamines in the nervous system.

  1959cited by this paper

• Lisuride: An 8-Alpha-Ergoline with Ergot Antagonistic Properties

  2021cites this paper
• Bromocriptine: Past And Present : From The In Vitro And In Vivo Experimental Studies To The Clinical Data

  2013cites this paper
• Amantadine Treatment of Hemispatial Neglect: A Double-Blind, Placebo-Controlled Study

  2007cites this paper
• Poststroke and Brain Injury Rehabilitation: Spatial Neglect

  2007cites this paper
• Kinematic Aiming Task: Measuring Functional Changes in Hand and Arm Movements After Botulinum Toxin-A Injections in Children with Spastic Hemiplegia

  2007cites this paper
• Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors

  2005cites this paper
• Hypothesis: Bromocriptine lacks intrinsic dopamine receptor stimulating properties

  2005cites this paper
• The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats

  2004influential citation
• The motor effects of bromocriptine — a review

  2004cites this paper
• Effects of lisuride on body temperature of rats and rabbits: Relation to microsomal biotransformation and dopaminergic receptor stimulation

  2004cites this paper
• Treatments of unilateral neglect: a review.

  2002cites this paper
• Dopamine agonists reorient visual exploration away from the neglected hemispace

  1998cites this paper
• A study on the effect and tolerance of lisuride on Parkinson's disease.

  1996cites this paper
• Effects of Bromocriptine on Dopamine Turnover with or without Levodopa

  1996cites this paper
• The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.

  1994cites this paper
• Clinical classification of dopaminergic effects in parkinsonism.

  1992cites this paper
• Behavioral characterization of the new potent nonselective dopamine agonist pergolide.

  1992cites this paper
• [The dopamine agonist, lisuride, in the therapy of Parkinson disease].

  1992cites this paper
• The Place of the Dopaminergic Agonists in the Treatment of Parkinson’s Disease: the View from the Trenches

  1992cites this paper
• Lisuride plus selegiline in the treatment of early Parkinson's disease

  1991cites this paper
• The rise of body temperature induced by the stimulation of dopamine D1 receptors is increased in acutely reserpinized mice.

  1990cites this paper
• Effects induced by chronic treatment with selective D1 or D2 antagonists on open‐field behavior and colonic temperature

  1990cites this paper
• Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice.

  1990cites this paper
• Lisuride Pharmacology and Treatment of Parkinson’s Disease

  1989cites this paper
• Stimulation of central D1 dopamine receptors reverses reserpine-induced hypothermia in mice.

  1989cites this paper
• Lisuride in de novo Parkinsonian patients: a four‐year follow‐up

  1988cites this paper
• Importance of D‐2 Mechanisms in the Reversal of Reserpine Hypothermia in the Mouse

  1988cites this paper
• Lisuride in Parkinson's disease. 4-year follow-up.

  1988cites this paper
• Agonist and antagonist actions of lisuride on dopamine neurons: electrophysiological evidence.

  1988cites this paper
• Parkinsonism—Drug Treatment: Part I

  1987cites this paper
• Low dose lisuride in advanced Parkinson disease

  1987cites this paper
• Dopaminergic activity of some ergot alkaloid derivatives: relationship to their chemical structure.

  1986cites this paper
• Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats.

  1986cites this paper
• Therapeutic effect of lisuride in advanced Parkinson's disease.

  1986cites this paper
• Lisuride and transdihydrolisuride: differences in action on central dopaminergic functions in dependence on the location and the state of receptors.

  1985cites this paper
• Effects of lisuride on blink reflex habituation in Parkinson disease.

  1985cites this paper
• Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.

  1985cites this paper
• Dopamine agonists in the treatment of dystonia.

  1985cites this paper
• The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.

  1985cites this paper
• Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?

  1985cites this paper
• [Current perspectives in the treatment of Parkinson disease].

  1985cites this paper
• Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.

  1985cites this paper
• Reserpine-induced hypothermia and its reversal by dopamine agonists.

  1985cites this paper
• [Lisuride in Parkinson disease].

  1985cites this paper
• Lisuride — a new drug for treatment of hyperprolactinaemic disorders

  1984cites this paper
• Tolerance to the behavioral effects of bromocriptine in cats.

  1984cites this paper
• Pergolide in the treatment of Parkinson's disease

  1984cites this paper
• The behavioral pharmacology of Ay‐27,110, a novel nonergot dopaminergic agonist

  1984cites this paper
• Dopaminagonisten bei Morbus Parkinson - neue pharmakologische und klinische Erkenntnisse, Entwicklungen und Probleme

  1984cites this paper
• Biochemical Pharmacology of Dopamine Receptors

  1984cites this paper
• Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat.

  1983cites this paper
• Acute treatment of Huntington's chorea with lisuride.

  1983cites this paper
• Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia.

  1983cites this paper
• Comparison of pergolide and bromocriptine therapy in parkinsonism

  1983cites this paper
• RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.

  1983cites this paper
• Intravenous administration of sulpiride and heat sensation on the body surface.

  1983cites this paper
• Influence of ergot derivatives on prolactin secretion in rats. Mechanisms of action and clinical implications

  1983cites this paper
• Lisuride in the treatment of parkinsonism.

  1983cites this paper
• Further studies with lisuride in Parkinson's disease.

  1983cites this paper
• Bromocriptine and lisuride in Parkinson disease

  1983cites this paper
• Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.

  1983cites this paper
• Lisuride in generalised dystonia and spasmodic torticollis.

  1982cites this paper
• The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.

  1982cites this paper
• Lisuride versus bromocriptine treatment in Parkinson disease

  1982cites this paper
• Gamma‐hydroxybutyrate in experimental myoclonus

  1982cites this paper
• Effects of ibotenic acid-induced neuronal degeneration in the medial preoptic area and the lateral hypothalamic area on sexual behavior in the male rat.

  1982cites this paper
• Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.

  1982cites this paper
• Multiple postsynaptic dopamine receptors and behavioral manifestation.

  1982cites this paper
• Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.

  1982cites this paper
• "On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment.

  1982cites this paper
• Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.

  1982cites this paper
• Beneficial effects of lisuride in Meige disease

  1982cites this paper
• Chapter 5 – Antiparkinsonian and antidyskinetic drugs

  1982cites this paper
• “On‐off” phenomena, dyskinesias and dystonias

  1982cites this paper
• Biochemical Pharmacology of Psychotomimetics

  1982cites this paper
• Direct binding of 3H-lisuride to adrenergic and serotonergic receptors.

  1981cites this paper
• Lisuride in parkinsonism

  1981cites this paper
• Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.

  1981cites this paper
• Binding of antiparkinsonian ergot derivatives to the dopamine receptor

  1981cites this paper
• Lisuride in Parkinson disease

  1981cites this paper
• Serotonergic and dopaminergic effects of yawning in the cat.

  1981cites this paper
• Treatment of advanced Parkinson's disease with dopamine agonists

  1981cites this paper
• Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.

  1981cites this paper
• The hypotheses of different dopamine receptor mechanisms.

  1981cites this paper
• Lisuride combined with levodopa in advanced Parkinson disease

  1981cites this paper
• Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants.

  1980cites this paper
• Effectiveness.of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states

  1980cites this paper
• Anorectic effect of lisuride and other ergot derivatives in the rat.

  1980cites this paper
• EVIDENCE OF PRESYNAPTIC DOPAMINE RECEPTORS IN SYMPATHETIC HEART NERVES OF CATS

  1980cites this paper
• Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics

  1979cites this paper
• Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents.

  1979cites this paper
• Lisuride in Parkinson's disease.

  1979cites this paper
• PHARMACOLOGICAL EFFECTS OF LISURIDE IN RODENTS MEDIATED BY DOPAMINERGIC RECEPTORS: MECHANISM OF ACTION AND INFLUENCE OF CHRONIC TREATMENT WITH LISURIDE

  1979cites this paper
• Pergolide and lisuride for Parkinson's disease.

  1979cites this paper